In silico analysis of CD34+ cell gene expression showed that CPE55 expression was reduced while both TLN1 and MSN were increased in MDS patients compared to healthy controls (Figure 7; Supplementary Tables 1D, E). This evidence concerns the gene CD34 and myelodysplastic syndrome.